Skip to main content
Log in

The effects of chronic alcohol ingestion and alcoholic liver disease on binding of drugs to serum proteins

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The binding of salicylate, sulphadiazine and phenylbutazone in whole serum of patients with alcohol-induced liver disease has been compared to that of chronic alcoholics with no evidence of liver disease, and normal healthy subjects. Binding of all three drugs was normal in the chronic alcoholic group, but decreased in patients with alcoholic liver disease. In subjects with alcoholic hepatitis, this decrease appeared to be correlated with variations in serum bilirubin and albumin levels. These observations may be of clinical relevance to the distribution of drugs in alcoholic patients with accompanying hepatic disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Affrime, M., Reidenberg, M. M.: The binding of drugs to plasma from patients with cirrhosis. Pharmacologist15, 207 (1973)

    Google Scholar 

  • Affrime, M., Reidenberg, M. M.: The protein binding of some drugs in plasma from patients with alcoholic liver disease. Europ. J. Clin. Pharmacol.8, 267–269 (1975)

    Google Scholar 

  • Dromgoole, S. H.: The binding capacity of albumin and renal disease. J. Pharmacol. Exp. Ther.191, 318–323 (1974)

    Google Scholar 

  • Hooper, W. D., Bochner, F., Eadie, M. J., Tyrer, J. H.: Plasma protein binding of diphenylhydantoin. Clin. Pharmacol. Ther.15, 276–282 (1974)

    Google Scholar 

  • Hooper, W. D., Dubetz, D. K., Bochner, F., Cotter, L. M., Smith, G. A., Eadie, M. J., Tyrer, J. H.: Plasma protein binding of carbamazepine. Clin. Pharmacol. Ther.17, 433–440 (1975)

    Google Scholar 

  • Koch-Weser, J.: Serum drug concentrations as therapeutic guides. New Eng. J. Med.287, 222–231 (1972)

    Google Scholar 

  • Olsen, G. D., Bennett, W. M., Porter, G. A.: Morphine and phenytoin binding to plasma protein in renal and hepatic failure. Clin. Pharmacol. Ther.17, 677–685 (1975)

    Google Scholar 

  • Powell, L. W., Axelsen, E.: Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding. Gut13, 690–696 (1972)

    Google Scholar 

  • Reidenberg, M. M.: Effect of disease states on plasma protein binding of drugs. Med. Clin. N. Amer.58, 1103–1109 (1974)

    Google Scholar 

  • Reidenberg, M. M., Affrime, M.: Influence of disease states on binding of drugs to plasma proteins. Ann. N. Y. Acad. Sci.226, 115–126 (1973)

    Google Scholar 

  • Thiessen, J. J., Sellers, E. M., Denbeigh, P., Dolman, L.: Plasma protein binding of diazepam and tolbutamide in chronic alcholics. J. Clin. Pharmacol.16, 345–351 (1976)

    Google Scholar 

  • Wallace, S., Brodie, M. J.: Decreased drug binding in serum from patients with chronic hepatic disease. Europ. J. Clin. Pharmacol.9, 429–432 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brodie, M.J., Boobis, S. The effects of chronic alcohol ingestion and alcoholic liver disease on binding of drugs to serum proteins. Eur J Clin Pharmacol 13, 435–438 (1978). https://doi.org/10.1007/BF00566322

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00566322

Key words

Navigation